PREEKLAMSIA BERAT

Authors

  • Soufni Morawati Universitas Baiturrahmah
  • Helwi Nofira Universitas Baiturrahmah

DOI:

https://doi.org/10.59003/nhj.v5i7.1800

Keywords:

Severe preeclampsia; Hypertensive disorders of pregnancy; Magnesium sulfate; Maternal morbidity; Perinatal outcomes

Abstract

Severe preeclampsia is a hypertensive disorder of pregnancy characterized by elevated blood pressure and signs of end-organ damage occurring after 20 weeks of gestation. This condition remains a major cause of maternal and perinatal morbidity and mortality worldwide. Severe preeclampsia may present with systolic blood pressure ≥160 mmHg or diastolic blood pressure ≥110 mmHg, accompanied by proteinuria or other manifestations such as thrombocytopenia, impaired liver function, renal insufficiency, pulmonary edema, and neurological disturbances. The pathophysiology involves abnormal placentation, endothelial dysfunction, and systemic inflammatory responses. Management of severe preeclampsia requires prompt diagnosis, close maternal and fetal monitoring, blood pressure control, seizure prophylaxis with magnesium sulfate, and timely delivery as definitive treatment. Early recognition and appropriate management are essential to reduce complications and improve maternal and neonatal outcomes.

Downloads

Download data is not yet available.

References

APBN. Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2020;135(6):e237–60.

Brown MA, Magee LA, Kenny LC. Hypertensive disorders of pregnancy. Hypertension. 2023;81(2):327–41.

Cunningham FG, Leveno KJ, Bloom SL. Williams Obstetrics. Edition 26th, editor. New York: McGraw-Hill Education; 2022.

Gallo DM, Wright A, Redman CW, Vatish M. Management of severe preeclampsia and HELLP syndrome. J Clin Med. 2023;12(19):6360.

Gynecologists AC of O and. Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. Obstet Gynecol. 2020;135(6):e237–60.

Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2022;399(10336):1116–31.

Mowatt L, Mowatt L. Orbital Cellulitis. Challenging Issues Parana Sinuses [Internet]. 2018;

Marchak A. Periorbital Cellulitis: Pathogenesis and Clinical Findings | Calgary Guide [Internet]. The Calgaryguide. 2018.

Marchak A. Orbital Cellulitis: Pathogenesis and Clinical Findings | Calgary Guide [Internet]. 2018.

Sharma DD. The Management of Preeclampsia: A Comprehensive Review. Curr Hypertens Rep. 2024;26(3):245–56.

Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Lancet. 2023;401(10375):1491–504.

Steegers EAP, von Dadelszen P, Duvekot JJ, Pijnenborg R. Preeclampsia. Lancet. 2023;401(10383):1493–506.

Downloads

Published

2025-12-30

How to Cite

Soufni Morawati, & Helwi Nofira. (2025). PREEKLAMSIA BERAT. Nusantara Hasana Journal, 5(7), 318–324. https://doi.org/10.59003/nhj.v5i7.1800

Most read articles by the same author(s)